OK so you thought the title of the other thread was out of date BUT unfortunately there is no way to edit thread titles.

So here is a new title

This one has got the charts at the top again & has a link to the old one.
http://www.moneyam.com/InvestorsRoom/posts.php?tid=5021

Directors selling shares may not be bad news - particularly at this time of year it may well be for tax reasons. IMHO we have interesting times ahead with OXB

Very strong sells again today.

Selling seems popular - my lot are all red !

I'm watching for the next buying opportunity.

This from bloomberg yesterday:
By Angela Zimm
March 21 (Bloomberg) -- Shares of Oxford Biomedica Plc, an
unprofitable U.K. biotechnology company, fell 8.1 percent after an
analyst raised concerns the company has yet to find a partner to
help develop its Trovax cancer treatment.
Shares of the Oxford, England-based company fell 1.75 pence
to 20 pence at the close of London trading. They've dropped 15
percent in the last 12 months.
Oxford Biomedica is ``unlikely'' to find a partner for
Trovax, its most advanced experimental product, until the end of
2005 when the company publishes data from a colon cancer study,
Code Securities analyst Chris Redhead said today in a note to
clients. The company relies on partnership and licensing
agreements with drugmakers for revenue.
``We now believe that partnering of Trovax, which accounts
for some two-thirds of Oxford Biomedica's value, is unlikely
before the survival data in colorectal cancer is available at the
end of 2005,'' Redhead said in the note.
Oxford Biomedica today said it narrowed its 2004 net loss to
10.6 million pounds ($20.1 million), or 2.9 pence a share,
compared with 10.7 million pounds, or 3.9 pence in 2003. Revenue
increased 34 percent to 502,000 pounds from 374,000 pounds.

The directors nearly always sell their options as otherwise they have to stump up a load of money. Historically they have sold at lowish prices, not at the high. Prelude had a large sell order which has now been cleared so the downside I think is limited. Speculators may have expected more news with the results but I don't know why, we should see this as an excellent opportunity to buy more as myself and apple do quite regularly, what price you looking at jumping back in apple? I last bought at 18, sold some at 23, but a lot has happened since. The article in the Independent is total rubbish, the price is hardlyfluffed up at this level, the price was higher before the takeover spec. These journos don't half write some dribble! Hlyeo98, you obviously want to get in on oxb, you'll be lucky to get 14p but should it get that low, I'll buy a tonne of em. Good luck in your de-ramping but most on this board have seen it all before. The results were not at all bad, the newsflow has all been good and on target, one day this co sp is going to go through the roof, and who knows when that may be, i'd hate to be out of them when it happens so always have a large core holding.

rvitler,

I'm looking for less than 18 but mainly I will keep an eye on the trades to try & spot when it turns around.

I like this share because I keep getting it right on this 1 :-)

Pretty depressing times at present especially after
reading the post today from elsmith.

My prediction of 35p by Mid-March 05 does not seem to clever
(well how I was I supposed to know the Trovax updates
and interims would not impress the City?).

However, I still have faith that this company will
come good this year and achieve 35p plus. As other's
any more dips in the share price represent good
buying opportunities.

Have a good Easter All!

rvitler, I'm not trying to de-ramp OXB...just read Bloomberg (as above) opinion and also Independent article and also several share analyst comments on OXB...you need to do some research on OXB and not just hide your head in the sands, rvitler.

If you want to hear it from the horses mouth, go to http://www.oxfordbiomedica.co.uk/ where you can now listen to the recording of Mondays OXB results webcast . You will be amazed how the sceptics can be so inventive.

You have to read between the lines, I think that the statement on Bloomberg is extremely positive as until now no-one has mentioned the need for a partnership - they're thinking it's too big for Oxb to handle on their own. Look forward to the news of licensing deals and partnership tie up - 8 mths is not a long time in this business, I have been patient for 8 yrs! I have held this share at 1.32 - there's no logic in share prices but when Trovax is accepted 2 target stands.

I watched the 1st few buys this morning & I increased my holding again, it looks like we are on the up again.

In profit on this morning's buy already.

UP 9.3% so far today.

Every single one of my holdings is showing blue today - what did I do right?

What a difference a day makes.
The smile's now back. Tee Hee Hee.

Pachandl What colour are you sun glasses. 8-)

Mind I do feel better to-day than yesterday.

Amazing how an up turn in health stocks makes you feel much better.

Thought it was mad going down on the results. Hope we've seen the last of the nervous and the co's sp is re-rated. 21p is so undervalued, Trovax alone could be worth Billions.

Fred - I'm not even wearing sunglasses. I am going home with a smile on my face.